Results 281 to 290 of about 20,100 (304)

Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors.

Neurological Sciences, 2023
L. Fionda, E. Rossini, Antonio Lauletta, L. Leonardi, Laura Tufano, R. Costanzo, P. Marchetti, Marco Salvetti, M. Garibaldi, S. Morino, Giovanni Antonini   +10 more
semanticscholar   +1 more source

Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

Journal of Neurology, 2022
C. Strano, Benedetta Sorrenti, L. Bosco, Y. Falzone, R. Fazio, M. Filippi   +5 more
semanticscholar   +1 more source

Refractory vitiligo improving with eculizumab

Dermatologic Therapy, 2020
Michal Bohdanowicz, Michal Bohdanowicz, Richard A. Wells, Richard A. Wells, Sylvia Aide Martínez-Cabriales, Sylvia Aide Martínez-Cabriales, Sylvia Aide Martínez-Cabriales, Neil H. Shear, Neil H. Shear   +8 more
openaire   +3 more sources

Eculizumab in refractory myasthenic crisis

Muscle & Nerve, 2018
Milvia Pleitez, Crystal Jing Jing Yeo
openaire   +3 more sources

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

British Journal of Haematology, 2020
Antonio M Risitano, Robert A Brodsky, Peter Hillmen   +2 more
exaly  

A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

Muscle and Nerve, 2013
James F Howard, Gary Cutter
exaly  

Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study

Frontiers in Neurology, 2020
Richard J Nowak, Srikanth Muppidi, Fanny O’brien   +2 more
exaly  

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

Journal of Thrombosis and Haemostasis, 2014
Massimo Cugno
exaly  

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

Clinical and Experimental Immunology, 2017
Ali Guermazi, Frank W Roemer
exaly  

Melanoma in a patient in treatment with eculizumab

Annals of Hematology, 2011
Manganoni AM, Pavoni L, FACCHETTI, Fabio, Farisoglio C, Sereni E, CALZAVARA PINTON, Piergiacomo   +5 more
openaire   +3 more sources